{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:40:21Z","timestamp":1778740821938,"version":"3.51.4"},"reference-count":16,"publisher":"Index Copernicus","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The paper presents the physicochemical and structural characteristics as well as the comparison of selected statins. Statins are relatively popular compounds used in modern medicine. They are increasingly often combined with other medications to improve the effectiveness of therapy. We analyzed the characteristics of pravastatin, simvastatin, atorvastatin, pitavastatin, lovastatin, mevastatin, fluvastatin, and rosuvastatin obtained from the PubChem Substance database. On the basis of data related to chemical structure and physicochemical properties, the statins were grouped into more and less similar ones. Statins are not homogeneous in terms of physicochemical properties and structure. Three groups of statins were identified. Mevastatin, lovastatin, and simvastatin are the most similar to each other, while pravastatin shows a slightly lower similarity to them. Pitavastatin and fluvastatin are also highly similar, while atorvastatin and rosuvastatin, because of their properties, are the most different from other statin groups.<\/jats:p>","DOI":"10.1515\/bams-2018-0034","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T09:00:51Z","timestamp":1545210051000},"source":"Crossref","is-referenced-by-count":2,"title":["The similarity of selected statins \u2013 a comparative analysis"],"prefix":"10.5604","volume":"14","author":[{"given":"Constantin","family":"Dreyer","sequence":"first","affiliation":[{"name":"Jagiellonian University \u2013 Medical College , \u015aw. Anny 12 , 31-008 Krakow , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Placha","sequence":"additional","affiliation":[{"name":"Jagiellonian University \u2013 Medical College , Chair of Medical Biochemistry , Kopernika 7 , 31-034 Krakow , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Zagajewski","sequence":"additional","affiliation":[{"name":"Jagiellonian University \u2013 Medical College , Chair of Medical Biochemistry , Kopernika 7 , 31-034 Krakow , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Dygut","sequence":"additional","affiliation":[{"name":"Jagiellonian University \u2013 Medical College , Department of Bioinformatics and Telemedicine , \u0141azarza 16 , 31-530 Krakow , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9773-6767","authenticated-orcid":false,"given":"Klaudia","family":"Stangel-W\u00f3jcikiewicz","sequence":"additional","affiliation":[{"name":"Jagiellonian University \u2013 Medical College , Gynecology and Oncology , Kopernika 23 , 31-501 Krakow , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Piwowar","sequence":"additional","affiliation":[{"name":"Jagiellonian University \u2013 Medical College , Department of Bioinformatics and Telemedicine , \u0141azarza 16 , 31-530 Krakow , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3689","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"2023010916524413972_j_bams-2018-0034_ref_001_w2aab3b7c54b1b6b1ab2b1b1Aa","unstructured":"Bizukoj\u00e6 M, Ledakowicz S. Biosynteza lowastatyny przez Aspergillus terreus. Biotechnologia Monografie 2005;2:55\u201367."},{"key":"2023010916524413972_j_bams-2018-0034_ref_002_w2aab3b7c54b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Sirtori CR. The pharmacology of statins. Pharmacol Res 2014;88:3\u201311.","DOI":"10.1016\/j.phrs.2014.03.002"},{"key":"2023010916524413972_j_bams-2018-0034_ref_003_w2aab3b7c54b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Be\u0142towski J, W\u00f3jcicka G, Jamroz-Wi\u015bniewska A. Adverse effects of statins \u2013 mechanisms and consequences. Curr Drug Saf 2009;4:209\u201328.","DOI":"10.2174\/157488609789006949"},{"key":"2023010916524413972_j_bams-2018-0034_ref_004_w2aab3b7c54b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Awad K, Banach M. The optimal time of day for statin administration: a review of current evidence. Curr Opin Lipidol 2018;29:340\u20135.","DOI":"10.1097\/MOL.0000000000000524"},{"key":"2023010916524413972_j_bams-2018-0034_ref_005_w2aab3b7c54b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Awad K, Serban M-C, Penson P, Mikhailidis DP, Toth PP, Jones SR, et al. Effects of morning vs evening statin administration on lipid profile: a systematic review and meta-analysis. J Clin Lipidol 2017;11:972\u201385.s.","DOI":"10.1016\/j.jacl.2017.06.001"},{"key":"2023010916524413972_j_bams-2018-0034_ref_006_w2aab3b7c54b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Plakogiannis R, Cohen H. Optimal low-density lipoprotein cholesterol lowering \u2013 morning versus evening statin administration. Ann Pharmacother 2007;41:106\u201310.","DOI":"10.1345\/aph.1G659"},{"key":"2023010916524413972_j_bams-2018-0034_ref_007_w2aab3b7c54b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. PubChem substance and compound databases. Nucleic Acids Res 2016;44:D1202\u201313.","DOI":"10.1093\/nar\/gkv951"},{"key":"2023010916524413972_j_bams-2018-0034_ref_008_w2aab3b7c54b1b6b1ab2b1b8Aa","unstructured":"Schr\u00f6dinger L. PyMOL: the PyMOL molecular graphics system. New York: Schr\u00f6dinger, LLC, 2018."},{"key":"2023010916524413972_j_bams-2018-0034_ref_009_w2aab3b7c54b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Cao Y, Charisi A, Cheng L-C, Jiang T, Girke T. ChemmineR: a compound mining framework for R. Bioinformatics 2008;24:1733\u20134.","DOI":"10.1093\/bioinformatics\/btn307"},{"key":"2023010916524413972_j_bams-2018-0034_ref_010_w2aab3b7c54b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Bader RF. Bond paths are not chemical bonds. J Phys Chem A 2009;113:10391\u20136.","DOI":"10.1021\/jp906341r"},{"key":"2023010916524413972_j_bams-2018-0034_ref_011_w2aab3b7c54b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Holliday JD, Salim N, Whittle M, Willett P. Analysis and display of the size dependence of chemical similarity coefficients. J Chem Inf Comput Sci 2003;43:819\u201328.","DOI":"10.1021\/ci034001x"},{"key":"2023010916524413972_j_bams-2018-0034_ref_012_w2aab3b7c54b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Cao Y, Jiang T, Girke T. A maximum common substructure-based algorithm for searching and predicting drug-like compounds. Bioinformatics. Oxford: Oxford University Press, 2008.","DOI":"10.1093\/bioinformatics\/btn186"},{"key":"2023010916524413972_j_bams-2018-0034_ref_013_w2aab3b7c54b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Maggiora G, Vogt M, Stumpfe D, Bajorath J. Molecular similarity in medicinal chemistry. J Med Chem 2014;57:3186\u2013204.","DOI":"10.1021\/jm401411z"},{"key":"2023010916524413972_j_bams-2018-0034_ref_014_w2aab3b7c54b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349\u201357.","DOI":"10.1056\/NEJM199811053391902"},{"key":"2023010916524413972_j_bams-2018-0034_ref_015_w2aab3b7c54b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The Effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001\u20139.","DOI":"10.1056\/NEJM199610033351401"},{"key":"2023010916524413972_j_bams-2018-0034_ref_016_w2aab3b7c54b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Carter NJ. Rosuvastatin. Am J Cardiovasc Drug 2010;10:383\u2013400.","DOI":"10.2165\/11204600-000000000-00000"}],"container-title":["Bio-Algorithms and Med-Systems"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/bams.2018.14.issue-4\/bams-2018-0034\/bams-2018-0034.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/bams-2018-0034\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/bams-2018-0034\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T10:08:11Z","timestamp":1719223691000},"score":1,"resource":{"primary":{"URL":"https:\/\/bamsjournal.com\/resources\/html\/article\/details?id=617646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,12,6]]},"published-print":{"date-parts":[[2018,12,19]]}},"alternative-id":["10.1515\/bams-2018-0034"],"URL":"https:\/\/doi.org\/10.1515\/bams-2018-0034","relation":{},"ISSN":["1896-530X","1895-9091"],"issn-type":[{"value":"1896-530X","type":"electronic"},{"value":"1895-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]},"article-number":"20180034"}}